Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-11

Clinical Trial Update: Remimazolam Besylate and Propofol Sedation on Hemodynamic for Coronary Artery Bypass Graft Patients [NA]

View source ↗

Summary

A clinical trial update describing a study of sedation using remimazolam besylate with propofol to manage hemodynamics in patients undergoing coronary artery by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROPOFOL (Propofol)
  • Remimazolam besylate (remimazolam besylate)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Coronary Artery Disease | NA | Status: NOT_YET_RECRUITING